A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated
NCT00233506
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG:
CpG 7909
Sponsor
University of Iowa
Collaborators
[object Object]
[object Object]
[object Object]